Capricor Therapeutics

1 trends tracked about this subject — the full history, oldest to newest below.

↓ Cooling Business

Capricor Therapeutics shares plunged after FDA staff flagged data and efficacy concerns regarding its Duchenne heart disease therapy.

9 sources 10 articles v 8 just now